| Date Filed | Type | Description |
| 06/08/2023 |
4
| Ainsworth Sean (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 10,976 shares
@ $0
Granted 9,639 options
@ $3.83, valued at
$36.9k
|
|
| 06/08/2023 |
4
| MANUSO JAMES S J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 10,976 shares
@ $0
Granted 9,639 options
@ $3.83, valued at
$36.9k
|
|
| 06/08/2023 |
4
| Pepose Jay (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 10,976 shares
@ $0
Granted 9,639 options
@ $3.83, valued at
$36.9k
|
|
| 06/08/2023 |
4
| Benton Susan (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 10,976 shares
@ $0
Granted 9,639 options
@ $3.83, valued at
$36.9k
|
|
| 06/08/2023 |
4
| Gallagher Cam (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 10,976 shares
@ $0
Granted 9,639 options
@ $3.83, valued at
$36.9k
|
|
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2023 |
4
| Sooch Mina (President and CEO) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 134,456 shares
@ $0
Granted 201,683 options to buy
@ $3.5, valued at
$705.9k
|
|
| 01/12/2023 |
4
| MANUSO JAMES S J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 18,544 shares
@ $0 |
|
| 01/12/2023 |
4
| Pepose Jay (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 13,013 shares
@ $0
Granted 33,291 options to buy
@ $3.5, valued at
$116.5k
|
|
| 01/12/2023 |
4
| Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 20,822 shares
@ $0 |
|
| 01/12/2023 |
4
| Hoffmann Bernhard (SVP of Corp. Dev. & Ops & Sec.) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 46,608 shares
@ $0
Granted 69,912 options to buy
@ $3.5, valued at
$244.7k
|
|
| 01/12/2023 |
4
| Zaremba Rabourn Amy (SVP of Finance) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 46,608 shares
@ $0
Granted 69,912 options to buy
@ $3.5, valued at
$244.7k
|
|
| 01/12/2023 |
4
| Benton Susan (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 16,267 shares
@ $0 |
|
| 01/06/2023 |
4
| Gallagher Cam (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Exercised (in-or-at-the-money) 1,574 options to buy
@ $0.0001, valued at
$0.2 |
|
| 10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2022 |
4
| MANUSO JAMES S J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Exercised (in-or-at-the-money) 787 options to buy
@ $0.0001, valued at
$0.1 |
|
| 10/04/2022 |
4
| Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Exercised (in-or-at-the-money) 3,148 options to buy
@ $0.0001, valued at
$0.3 |
|
| 09/08/2022 |
4
| Sooch Mina (President and CEO) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Exercised (in-or-at-the-money) 1,023 options to buy
@ $0.0001, valued at
$0.1 |
|
| 07/06/2022 |
4
| Benton Susan (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 6,335 shares
@ $0
Granted 12,376 shares
@ $0 |
|
| 07/06/2022 |
4
| Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 7,812 shares
@ $0
Granted 15,841 shares
@ $0 |
|
| 07/06/2022 |
4
| MANUSO JAMES S J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 14,108 shares
@ $0 |
|
| 07/06/2022 |
4
| Pepose Jay (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 9,900 shares
@ $0 |
|
| 06/15/2022 |
4
| Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.93, valued at
$38.6k
|
|
| 06/15/2022 |
4
| Gallagher Cam (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.93, valued at
$38.6k
|
|
| 06/15/2022 |
4
| MANUSO JAMES S J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.93, valued at
$38.6k
|
|
| 06/15/2022 |
4
| Benton Susan (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.93, valued at
$38.6k
|
|
| 06/15/2022 |
4
| Pepose Jay (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.93, valued at
$38.6k
|
|
| 06/15/2022 |
4
| Ainsworth Sean (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.93, valued at
$38.6k
|
|
| 05/24/2022 |
4
| MANUSO JAMES S J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Bought 5,000 shares
@ $1.99, valued at
$10k
|
|
|